uMotif

uMotif is excited to attend and sponsor #PatientsasPartnersinClinicalResearch. #Patientcentricity is at the heart of our #eCOA, #ePRO, and #eConsent solutions—which are designed to create better experiences for #clincialtrial patients & site professionals.

uMotif is heading to Berlin for #ACDM. Visit us in booth 9 to experience the latest in #eCOA, #ePRO & #eConsent innovation & see how it’s transforming #clinicaltrials for patients & sites. #patientcentric #patientsiterelationship

Discover the uMotif advantage: All-in-one, #patientcentric #eCOA and #eConsent platform with robust tools to strengthen the critical #patientsiterelationship – global, scalable, proven and ready to adapt to your requirements. Book a demo today. tinyurl.com/bdfbf22h

#COGUK was a great event—inspiring & insightful conversations in the booth & our #eCOA innovation workshop. Next up…#ACDM in Berlin. See you there! #ePRO #clinicaltrials #eConsent #patientcentric #patientsiterelationship

Setting your schedule for #COGUK? Don’t miss uMotif’s workshop on how to use #eCOA innovations to improve data quality & increase patient engagement.

We had a great few days at #OCTWestCoast…and the sunshine was a welcome bonus. Next stop….#COGUK March 3-4. See you there!

We’re ready for #OCTWestCoast. Visit uMotif at booth 71 to see how our modern #eConsent and #eCOA / #ePRO solutions drive more productive #clinicalresearchprograms and #realworldstudies by prioritizing the patient journey with easy to use technology.

We had a great week @ #SCOPE2026. A lot of excitement around how #eCOA / #ePRO, #eConsent & #AI can transform the #patient-site relationship & #clinicaltrial experience. See you next week at #OCTWest

#EverestGroup #MajorContender Status, #AIassistant innovation, thought leadership in #Nature, and strong growth. What do all these have in common? uMotif accomplishments in 2026. Get the full story: umotif.com/news/umotif-ea….

What does the combination of next-gen digital #clinicaltrial technology & #AI mean for the #patient-site relationship? Join uMotif CEO Steve Rosenberg on February 3rd @ 12:45 p.m. when he shares unique insights on what to expect.

We can’t wait to see you @ #SCOPE2026. Stop by Booth 1014 to see how uMotif #eCOA  / #ePRO & #eConsent innovation improves the #clinicaltrial experience for #patients & sites while boosting study productivity.

Welcome Chris Schlotterer, Director, Business Development, as the newest member of the uMotif team. We’re excited for Chris’ contributions as we provide innovative #eCOA, #ePRO & #eConsent solutions that strengthen the critical #clinicaltrial patient/site relationship.

How will #AI change the #clinicalresearch landscape this year & into the future? Industry leaders Adrian Hsing, Steve Rosenberg, Artem Andrianov, PhD, Rick Landin & Ming Tan will share front-line insights Jan. 22 @ the #Biostatistics Symposium of S. Cal. #BSSC26

uMotif kicks off the winter conference circuit at #SCOPESummit26, followed by #OCTWest, #COGNordics, #ACDM & #COGUK. We’re excited to show how our #eCOA/#ePRO & #eConsent solutions extend #patientcentricity & strengthen the critical #clinicaltrial patient/site relationship.

#2026 PharmaPhorum Perspectives: Why uMotif’s Bruce Hellman believes #patientcentricity & stronger #clinicaltrial patient-site relationships are more critical than ever in the era of #AI and #decentralized trials. Read & learn more umotif.com/news/imperativ….

Licensing & translations for #clinicaloutcomeassessment (#COA) remain major pain points for #clinicaltrial set up. uMotif’s Florence Mowlem, PhD offers practical solutions to barriers in a new Applied Clinical Trials article. Read & discover answers. umotif.com/news/the-chall…

Clinical Research News #Trendspotting #2026: uMotif CEO Steve Rosenberg highlights #AI—sharing his hopes for the positive ways this powerful tool can transform #lifesciences and urging caution about the danger of misuse. Read the full article here: umotif.com/news/trendspot…

#Clinicaltrials succeed when patients & sites are a unified team. But this gets harder with decentralization & technology proliferation. Steve Rosenberg shares how innovation can strengthen vs. strain the #patient-site relationship in a new ICT feature. tinyurl.com/4arnrdmh

The new episode of Life Sciences Decoded is live! uMotif’s Steve Rosenberg discusses the industry’s responsibility to ease the #clinicaltrial patient journey and uMotif’s work to improve the pivotal patient-site relationship. Listen here: lifesciencesdecoded.com/umotif.html

The uMotif team wishes you a joyful holiday season and a healthy and bright #2026. #happyholidays #newyear